Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U0QQ
|
|||
| Drug Name |
Tetra-substituted urea derivative 1
|
|||
| Synonyms |
PMID26413912-Compound-53
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
BIAL PORTELA & CA SA [PT]
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H18N4O
|
|||
| Canonical SMILES |
CN(C1CCCCC1)C(=O)N2C3=CC=CC=C3N=N2
|
|||
| InChI |
1S/C14H18N4O/c1-17(11-7-3-2-4-8-11)14(19)18-13-10-6-5-9-12(13)15-16-18/h5-6,9-11H,2-4,7-8H2,1H3
|
|||
| InChIKey |
ATPCFTJMZOBYDC-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.